- Home
- FLUX vs GNTA Comparison
FLUX vs GNTA Comparison
Compare FLUX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLUX | GNTA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 19.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLUX | GNTA |
|---|---|---|
| Price | $1.05 | $0.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 126.5K | 62.5K |
| Earning Date | 05-07-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,317,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.01 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 126.25 | N/A |
| 52 Week Low | $0.97 | $0.59 |
| 52 Week High | $7.55 | $10.00 |
Technical Indicators
Market Signals| Indicator | FLUX | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 43.91 |
| Support Level | $1.04 | $0.71 |
| Resistance Level | $1.52 | $1.70 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 23.03 | 43.87 |
Price Performance
Historical ComparisonAbout FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.